 | Up a level |
Number of items: 1.
Tempero, M., Oh, D-Y, Tabernero, J., Reni, M., Van Cutsem, E., Hendifar, A., Waldschmidt, D-T, Starling, N., Bachet, J-B, Chang, H-M, Maurel, J., Garcia-Carbonero, R., Lonardi, S., Coussens, L. M., Fong, L., Tsao, L. C., Cole, G., Jr., James, D. and Macarulla, T. (2021). Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study. Ann. Oncol., 32 (5). S. 600 - 609. AMSTERDAM: ELSEVIER. ISSN 1569-8041